Related Experiment Video
Updated: Jan 29, 2026

Reverse Yeast Two-hybrid System to Identify Mammalian Nuclear Receptor Residues that Interact with Ligands and/or Antagonists
Published on: November 15, 2013
Nuclear receptor ligands induce TREM-1 expression on dendritic cells: analysis of their role in tumors
Raffaella Fontana1, Laura Raccosta1, Lucrezia Rovati1
1Immuno-Biotherapy of Melanoma and Solid Tumors Unit, Division of Experimental Oncology, IRCCS Scientific Institute San Raffaele, Milan, Italy.
Abstract:
Dendritic cells (DCs) initiate adaptive immune responses after their migration to secondary lymphoid organs. The LXR ligands/oxysterols and the RXR ligand 9-cis Retinoic Acid (9-cis RA) were shown to dampen DC migration to lymphoid organs through the inhibition of CCR7 expression. We performed transcriptomics of DCs undergoing maturation in the presence of the LXR ligand 22R-Hydroxycholesterol (22R-HC). The analysis highlighted more than 1500 genes modulated by 22R-HC treatment, including the triggering receptor expressed on myeloid cells (TREM)-1, which was found markedly up-regulated. We tested the effect of other nuclear receptor ligands (NRL) and we reported the induction of TREM-1 following RXR, RAR and VDR activation. From a functional point of view, triggering of TREM-1 induced by retinoids increased TNFα and IL-1β release, suggesting an active role of NRL-activated TREM-1+ DCs in inflammation-driven diseases, including cancer. Consistently with this hypothesis we detected DCs expressing TREM-1 in pleural effusions and ascites of cancer patients, an observation validated by the induction of TREM-1, LXR and RAR target genes when monocyte-DCs were activated in the presence of tumor-conditioned fluids. Finally, we observed a better control of LLC tumor growth in Trem-1 bone marrow chimera mice as compared to wild type chimera mice. Future studies will be necessary to shed light on the mechanism of TREM-1 induction by distinct NRL, and to characterize the role of TREM-1+ DCs in tumor growth.
Insights
Nuclear receptor ligands modulate dendritic cell (DC) function, up-regulating TREM-1. This receptor
Area of Science:
- Immunology
- Molecular Biology
- Cell Biology
Background:
- Dendritic cells (DCs) are crucial for initiating adaptive immunity via migration to lymphoid organs.
- Nuclear receptor ligands, such as LXR ligands and 9-cis Retinoic Acid (9-cis RA), can inhibit DC migration by suppressing CCR7 expression.
Purpose of the Study:
- To investigate the impact of LXR ligand 22R-Hydroxycholesterol (22R-HC) on DC maturation using transcriptomics.
- To explore the role of nuclear receptor ligands (NRLs) in modulating TREM-1 expression and function in DCs.
- To assess the involvement of TREM-1+ DCs in cancer and tumor growth.
Main Methods:
- Transcriptomic analysis of DCs treated with 22R-HC.
- Testing the effects of various nuclear receptor ligands (NRLs) on TREM-1 expression.
- Functional assays assessing cytokine release (TNFα, IL-1β) upon TREM-1 triggering.
- Detection of TREM-1+ DCs in cancer patient samples (pleural effusions, ascites).
- In vivo studies using Trem-1 bone marrow chimera mice to evaluate tumor growth control.
Main Results:
- 22R-HC modulated over 1500 genes in maturing DCs, notably up-regulating TREM-1.
- RXR, RAR, and VDR activation also induced TREM-1 expression.
- Retinoid-induced TREM-1 triggering enhanced TNFα and IL-1β release.
- TREM-1+ DCs were detected in cancer patient effusions and ascites.
- Tumor-conditioned media induced TREM-1 and related target genes in monocyte-derived DCs.
- Trem-1 deficient mice showed improved control of LLC tumor growth compared to wild-type controls.
Conclusions:
- Nuclear receptor ligands significantly influence DC function, including the induction of TREM-1.
- NRL-activated TREM-1+ DCs play a role in inflammation and potentially cancer.
- TREM-1 expression in DCs is relevant in the tumor microenvironment and impacts tumor growth.
Related Concept Videos
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
Internal Receptors
Transducer Mechanism: Nuclear Receptors
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
Ligand Binding and Linkage
Nuclear Export of mRNA
Cell Specific Gene Expression

